B i b l i o g r a p h y

Argyll-Robertson, Douglas. "Case of Filaria loa in which the parasite was removed from under the conjunctiva," Transactions of the Ophthalmological Societies of the United Kingdom, Vol. 15: 1895, 137 – 167.

Ash, LR, Orihel, TC. Atlas of Human Parasitology. Chicago: American Society of Clinical Pathologists, 1997.

Blum J, Wiestner A, et al., "Encephalopathy following Loa loa treatment with albendazole," Acta Tropica,15 January 2001, 63-5.

Burnham, Gilbert "Ivermectin where Loa loa is endemic" The Lancet, 5 July 1997, 2–3.

Carme B, Boulesteix J, et al. "Five cases of encephalitis during treatment of loiasis with diethylcarbamazine," American Journal of Tropical Medicine and Hygiene, June 1991, 684-90.

Cully DF, Vassilatis DK et al., "Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans," Nature. 20 October1994, 707-11.

Despommier, DD, Gwadz, RW, et al, Parasitic Diseases. NY: Springer-Verlag,1994.

Fobi G, Gardon J, et al., "Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia," Ophthalmic Epidemiol. March 2000, 27-39.

Garcia A, Abel L, et al., "Longitudinal survey of Loa loa filariasis in southern Cameroon: long-term stability and factors influencing individual microfilarial status," American Journal of Tropical Medicine and Hygiene, April 1995, 370-5.

Garcia, Lynne. Diagnostic Medical Parasitology. Washington, DC: ASM Press, 2001.

Gardon, Jacques; Gardon-Wendel, Nathalie, et al., "Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection, Lancet , " 5 July 1997, 18-22.

Klion AD, Massougbodji A, et al.,"Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation". Journal of Infectious Disease, June 1991,1318-25.

Klion AD, Eisenstein EM, et al. "Pulmonary involvement in loiasis," American Review of Respiratory Disease. April 1992, 961-3.

Klion AD, Massougbodji A, et al. "Albendazole in human loiasis: results of a double-blind, placebo-controlled trial," Journal of Infectious Disease. July 1993, 202-6.

Klion AD, Ottesen EA, Nutman TB. "Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up," Journal of Infectious Disease. March 1994, 604-10.

Klion AD, Horton J, Nutman TB et al. "Albendazole therapy for loiasis refractory to diethylcarbamazine treatment" Clinical Infectious Disease, September 1999, 680-2.

Leiper, Robert, "Report of the Helminthologist for the Half Year Ending 30, April 1913," in Report of the Advisory Commision on Tropical Diseases Research Fund. 1913 – 1914.

Limaye AP, Abrams JS et al. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. Journal of Experimental Medicine.1 July1990,399-402.

Liu, Leo, et al. "Drug Therapy: Antiparasitic Drugs," New England Journal of Medicine, 2 May 1996, 1178 – 1184.

Orihel, TC, Lowrie RC, "Loa loa: Development to the infective stage in an American deerfly, Chrysops atlanticus," American Journal of Tropical Medicine and Hygiene, Vol. 24,1975, 610 - 615

Martin-Prevel Y, Cosnefroy JY, Ngari P, Pinder M., "Reduction of microfilaraemia with single high-dose of ivermectin in loiasis," Lancet, 14 August 1993, 442.

Martin-Prevel Y, Cosnefroy JY, "Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis," American Journal of Tropical Medicine and Hygiene, February 1993, 186-92.

Nutman TB, Miller KD, et al.,"Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study," New England Journal of Medicine, 22 September 1988, 752-6.

Sun, Tsieh. Parasitic Disorders: Pathology, Diagnosis, and Management. Baltimore:Williams & Wilkins, 1988.

Thomson MC, Obsomer V, et al., "Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa," Lancet, 23 September 2000,1077-8.

Ungeheuer MN, et al., "Cellular responses to Loa loa experimental infection in mandrills (Mandrillus sphinx) vaccinated with irradiated infective larvae" Parasite Immunology, 22 April 2000, 173-83.